AgreementAgreement • August 10th, 2010 • Sinobiopharma, Inc. • Pharmaceutical preparations
DongYing has obtained the approval of clinical trial of Eplerenone, and wants to manufacture Eplerenone in a production base which fulfills all the national requirements for medicine production. LianHuan has such production base and wants to co-develop Eplerenone with DongYing in order to be the first one in China to obtain the New Drug Certificate.
